Clinical Trial Update: Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Taxoprexin Injection to Dacarbazine for metastatic malignant melanoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Taxoprexin Injection

Snippet

Sponsor: American Regent, Inc. | Conditions: Malignant Melanoma | Phase 3 | Status: TERMINATED